Journal profile · Medicine-Medicine (all)
Experientia supplementum (2012)
ISSN 1664-431X · eISSN 2504-3692 · Springer Nature
Experientia supplementum (2012): subscription journal; 0 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
Experientia supplementum (2012) is published by Springer Nature. By OpenAlex counts of its recent articles, its largest topics are Glycosylation and Glycoproteins Research, Monoclonal and Polyclonal Antibodies Research and Immune Response and Inflammation, together about 25.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Experientia Supplementum (EXS) is a multidisciplinary book series originally created as a supplement to the journal Experientia which appears now under the cover of Cellular and Molecular Life Sciences. The edited volumes focus on selected topics of biological or biomedical research, discussing current methodologies, technological innovations, novel tools and applications, new developments and recent findings. The series is a valuable source of information not only for scientists and graduate students in medical, pharmacological and biological research, but also for physicians as well as practitioners in industry.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Medicine (all)
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glycosylation and Glycoproteins ResearchBiochemistry, Genetics and Molecular Biology9%
- Monoclonal and Polyclonal Antibodies ResearchMedicine8.5%
- Immune Response and InflammationImmunology and Microbiology7.6%
- Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology7.1%
- Parasitic Infections and DiagnosticsImmunology and Microbiology6.6%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology5.7%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology5.2%
- Electrochemical sensors and biosensorsEngineering4.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
CiteScore quartiles (Scopus, June 2026 release)
| Subject | Quartile | Rank | Percentile |
|---|---|---|---|
| Infectious Diseases | Q1 | 22/361 | 94th |
| Genetics | Q1 | 25/357 | 93rd |
| Medicine (miscellaneous) | Q1 | 32/466 | 93rd |
| Endocrinology | Q1 | 11/132 | 92nd |
| Oncology | Q1 | 42/428 | 90th |
| Molecular Biology | Q1 | 48/414 | 88th |
Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub
Database indexing
ScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINECASPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- CiteScore 2026-06
- 12LetPub ·
- SJR 2026-06
- 0LetPub ·
- SNIP 2026-06
- 0LetPub ·
- h-index
- 22OpenAlex ·
- i10-index
- 55OpenAlex ·
- 2-year mean citedness
- 0.33OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 136 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 15 | 0 | 106 |
| 2025 | 0 | 0 | 228 |
| 2024 | 0 | 0 | 314 |
| 2023 | 0 | 0 | 266 |
| 2022 | 26 | 5 | 231 |
| 2021 | 20 | 3 | 151 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Fees & open access
APC and open-access policy
Subscription journalLetPub
A subscription journal: articles are read by subscription or purchase, and authors usually pay no publication charge.
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted1
- book titles in this seriesBook titles in this seriesLength not stated
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- ISSN
- 1664-431X
- Electronic ISSN
- 2504-3692
- Official links
- Journal homepage ↗OpenAlex
FAQ
Frequently asked questions about Experientia supplementum (2012)
Which databases index Experientia supplementum (2012)?
According to LetPub and DOAJ records, Experientia supplementum (2012) is indexed in Scopus. The journal's website also lists MEDLINE and CAS; that list has not been checked against each database.
Is Experientia supplementum (2012) open access, and what is the APC?
Experientia supplementum (2012) is a subscription journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .